Medicaid is required to cover almost all drugs, but Congress specifically excluded those for weight loss. Even so, 16 states now cover Wegovy. Others are considering it, but it could strain budgets.

A economic research study shows that oncologists' prescribing habits change after they've been visited by pharmaceutical sales reps — and it also shows the changes do not extend patients' lives.

Drugmakers make big profits in the U.S. But many pay taxes far below the 21% corporate tax rate. Pfizer's effective tax rate is so low it's getting a big refund despite booking $59 billion in revenue.

OPill, the first over-the-counter birth control pill available without a prescription, is shipping to retailers nationwide.

The online pharmacy of entrepreneur Mark Cuban is adding two brand new Bayer drugs to its disruptor model, which relies on a radical transparency compared to the rest of the industry.

Drugmaker Biogen is pulling the plug on its controversial Alzheimer's drug Aduhelm, following disappointing sales. It had been expected to be a blockbuster product.

January is when drug makers typically hike their prices. This year, there's a mixed bag of price increases and a few notable declines, such as on some forms of insulin.

A popular asthma inhaler is being discontinued. Although there is a generic version, the switch could lead to disruptions in care because not all insurance companies are covering it.

The U.S. Supreme Court on Wednesday said it will review a lower court decision that would make mifepristone, the commonly used abortion pill, less accessible.

The National Institutes of Health has been reluctant to use its leverage as a biomedical research funder to influence drug pricing. Sen. Bernie Sanders is pressing NIH's new director to take action.

Pharmacists struggle to find key medicines and now have to anticipate drug shortages caused by extreme weather and global instability.

Shortages of drugs ranging from life-saving chemotherapies to basic generics are straining the health care system. Hospitals are adapting to chronic interruptions in the supply of medicines.

Despite at least nine lawsuits against the government, all companies whose drugs are up for Medicare price negotiation will come to the bargaining table.

After making a deal to free Americans held in Iran, the U.S. is looking with other countries to find ways to stop countries from making arbitrary arrests.

Many people taking Ozempic and related drugs have reported mental health concerns. Those side effects aren't in Ozempic's instructions for use. Are the problems a coincidence or related to the drug?

The science of baby babble is surprisingly complex. And the idea that a baby exposed to two languages will be confused? Let's see what babble researchers have to say about that.

The pharmaceutical industry has long said that any attempts to control drug prices would mean disaster for their research and development efforts. But the research doesn't back that up.

The government will negotiate new prices for the commonly prescribed drugs, but the cuts won't take effect until 2026. In the meantime, drugmakers are fighting the negotiations with lawsuits.

The Food and Drug Administration has approved approve the first RSV vaccine that can be given during pregnancy to protect newborn babies.

The Food and Drug Administration has approved the first vaccine for expectant mothers to shield their babies from RSV.